Invetx is a leading innovative veterinary therapeutics company that is focused on revolutionizing animal health through biopharmaceuticals. With a team of R&D leaders from the fields of human biotech and animal health, Invetx is building the premier biotechnology platform for protein-based therapeutics in animal health. Their goal is to elevate the standard of care for animals by developing highly targeted and effective therapies for diseases and chronic conditions such as pain, allergy, cancer, and diabetes.

By leveraging the advancements in biopharma technologies, Invetx aims to deliver improved health outcomes for both pets and farm animals. In the field of veterinary medicine, biopharmaceuticals have tremendous untapped potential. Invetx is closing this innovation gap by partnering with best-in-class biotechnology companies and collaborating with industry experts, veterinary scientists, and clinicians.

Backed by dedicated investors, Invetx offers a highly dynamic and rewarding work environment, making it an attractive partner for companies and experts in the field. Contact them at their Boston office to learn more about their innovative approach to animal health